Using Pb-203/212 for imaging and treating prostate cancer
Leveraging Pb-203/212 for the Theranostic Imaging and Therapy of Prostate Cancer
This study is exploring new ways to see and treat prostate cancer using special imaging techniques and targeted therapies, which could help patients get better care and improve their treatment results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11063509 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging techniques and therapies for prostate cancer using Pb-203 and Pb-212. By leveraging molecular imaging, the team aims to non-invasively visualize cancer biology and quantify the disease's characteristics. The approach combines expertise in radiochemistry, cancer biology, and engineering to create theranostic agents that can both diagnose and treat cancer effectively. Patients may benefit from improved imaging methods that enhance treatment precision and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with prostate cancer who are seeking innovative imaging and treatment options.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with prostate cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnosis and targeted therapies for prostate cancer patients.
How similar studies have performed: Previous research has shown promise in using molecular imaging techniques for cancer diagnosis and treatment, indicating a strong potential for success in this area.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Lewis, Jason S. — Sloan-Kettering Inst Can Research
- Study coordinator: Lewis, Jason S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.